Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Dennae Dalton

Physician Assistant, Medical Zionsville, IN Physician Assistant

NPI 1144494832 CMS profile 10966367

6639 Whitestown Pkwy, Zionsville, IN 46077

Open in the dashboard

General payments

$32,938

1,186 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Dennae Dalton of Zionsville, IN is reported in the CMS Open Payments database as having received $32,938 across 1,186 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Physician Assistant, Medical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $17,921 249
2024 General $3,916 262
2023 General $4,427 249
2022 General $4,093 242
2021 General $2,581 184

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Dennae Dalton
  • Physician Assistant, Medical median
  • Middle half of Physician Assistant, Medical
  • National median

In program year 2025, general payments to Dennae Dalton were reported at $17,921. Among 16,675 Physician Assistant, Medical profiles paid that year, the median was $214 and the middle half received between $62 and $755.

Show as a table
Year Dennae Dalton Physician Assistant, Medical median Middle half National median
2019 $0 $61 $19–$193 $163
2020 $0 $20 $14–$64 $114
2021 $2,581 $156 $41–$563 $132
2022 $4,093 $185 $55–$649 $149
2023 $4,427 $199 $58–$717 $160
2024 $3,916 $206 $62–$740 $164
2025 $17,921 $214 $62–$755 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Galderma Laboratories, L.P. $12,888 75 payments
  2. Journey Medical Corporation $2,766 13 payments
  3. AbbVie, Inc. $2,618 166 payments
  4. Pfizer Inc. $1,792 91 payments
  5. Novartis Pharmaceuticals Corporation $1,665 138 payments
  6. Janssen Biotech, Inc. $1,554 81 payments
  7. Sun Pharmaceutical Industries Inc. $1,505 105 payments
  8. E.R. Squibb & Sons, L.L.C. $1,095 35 payments
  9. Dermavant Sciences, Inc. $866 79 payments
  10. Lilly USA, LLC $696 45 payments
  11. Other $5,493 358 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $18,167 1,163 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $12,225 7 payments
  3. Travel and Lodging $1,320 2 payments
  4. Education $927 13 payments
  5. Consulting Fee $300 1 payment
Products named General payments · program years 2021–2025
  1. NEMLUVIO $11,944 27 payments
  2. TREMFYA $1,557 78 payments
  3. CIBINQO $1,365 79 payments
  4. RINVOQ $1,291 83 payments
  5. SKYRIZI $1,055 60 payments
  6. SOTYKTU $1,017 35 payments
  7. VTAMA $1,016 93 payments
  8. LITFULO $953 50 payments
  9. DUPIXENT $889 41 payments
  10. EUCRISA $796 57 payments
  11. Other $11,512 814 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 15 drugs

Part D claims

557

Median for Physician Assistant: 241

Drug cost

$88,317

Median for Physician Assistant: $4,110

Branded share of claims

8.1%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Taltz Autoinjector Ixekizumab Brand 11 $73,943
Clobetasol Propionate Generic 130 $5,105
Ketoconazole Generic 127 $2,022
Fluorouracil Generic 31 $1,726
Tretinoin Generic 20 $1,366
Triamcinolone Acetonide Generic 87 $1,037
Metronidazole Generic 19 $910
Valacyclovir Valacyclovir Hcl Brand 22 $597
Doxycycline Hyclate Generic 17 $580
Spironolactone Generic 18 $285

The 10 drugs with the highest cost, of 15 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 21 billing codes

Paid by Medicare

$61,089

Of which drugs: $124

Medicare patients

504

Average age 73

Services billed

2,025

306 women, 198 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 65%
Arthritis 38%
Ischemic heart disease 25%
Diabetes 20%
Depression 19%
Osteoporosis 17%
Cancer 16%
Chronic kidney disease 15%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 27 204 $124

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 23 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
RINVOQ
$400 — —
VTAMA
$378 — —
TREMFYA
$350 — —
CIBINQO
$277 — —
Zoryve
$229 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 23 in the dashboard with a free account

Records

1,186 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant, Medical in Indiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record